Company news

Simulations Plus, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results

July 1, 2024

Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date

June 17, 2024

Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum

June 11, 2024

Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software

May 14, 2024

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

April 2, 2024

Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date

March 19, 2024

Simulations Plus Launches Corporate Development Initiative

February 12, 2024

Simulations Plus Releases GastroPlus® Version 9.9

January 29, 2024

Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant

January 8, 2024

Simulations Plus Reports First Quarter Fiscal 2024 Financial Results

January 2, 2024

Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth

January 2, 2024

Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date

December 19, 2023

Simulations Plus Outlines Paths to Win at 2023 Investor Day

November 13, 2023

Simulations Plus to Host Investor Day on Tuesday, November 14th

October 30, 2023

Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results

October 24, 2023

Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

October 10, 2023

Simulations Plus Receives New FDA Grant Award

September 20, 2023

Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)

August 23, 2023

Simulations Plus Releases ADMET Predictor® 11

July 12, 2023

Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results

July 5, 2023

Simulations Plus Announces Third Quarter Fiscal Year 2023 Earnings and Conference Call Date

June 20, 2023

Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities

June 19, 2023

Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes

May 9, 2023

Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses

April 17, 2023

Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results

April 4, 2023

Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology

March 27, 2023

Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call

March 20, 2023

Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds

March 14, 2023

Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool

February 8, 2023

Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure

January 11, 2023

Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement

January 10, 2023

Simulations Plus Reports First Quarter Fiscal 2023 Financial Results

January 3, 2023

Simulations Plus Sets Date for First Quarter Fiscal Year 2023 Earnings Release and Conference Call

December 18, 2022

Simulations Plus and the University of Bath Awarded New FDA Grant

November 14, 2022

Simulations Plus 25th Anniversary Celebration Concludes with $25,000 Gift to Nonprofit, Girls Who Code

November 2, 2022

Simulations Plus Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results

October 25, 2022

Simulations Plus Announces Cash Dividend

October 19, 2022

Simulations Plus Releases GastroPlus® Version 9.8.3

October 11, 2022

Simulations Plus Sets Date for Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call

October 10, 2022

Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease

August 30, 2022

Simulations Plus Enters New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa)

August 3, 2022

Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer

July 20, 2022

Simulations Plus Realizes Early Success with its Concierge Program

July 13, 2022

Simulations Plus Reports Third Quarter Fiscal 2022 Financial Results

July 5, 2022

Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call

June 20, 2022

Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)

May 25, 2022

Simulations Plus Successfully Delivers FDA-Funded Project

April 27, 2022

Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software

April 20, 2022

Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results

April 5, 2022

Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software

March 28, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 141 decks. Every deck is listed under its year.